INHIBITION OF INTERLEUKIN-2 SYNTHESIS AND INTERLEUKIN-2 RECEPTOR-ALPHA EXPRESSION ON T-CELLS BY A CELL-FREE FACTOR DERIVED FROM A CD4+ REGULATORY T-CELL CLONE

被引:1
作者
OKINO, T
CHAKRABORTY, NG
STABACH, P
TWARDZIK, DR
PADULA, SJ
MUKHERJI, B
机构
[1] Department of Medicine, University of Connecticut, Health Center, Farmington
[2] Department of Oncogen, Seattle
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1993年 / 68卷 / 03期
关键词
D O I
10.1006/clin.1993.1126
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have shown that certain CD4+ T cell lines can function as suppressor cells in a cell culture system. In this context, the CD4+ T cells (AS-9) cloned from the peripheral blood lymphocytes (PBL) of a melanoma patient are capable of suppressing the induction of cytolytic response in autologous PBL in coculture. Here we show that a trypsin-sensitive cell-free culture supernatant factor from the AS-9 cells, AS-9 SF, interferes with IL-2 synthesis by T cells when they are stimulated. AS-9 SF also selectively blocks the expression of interleukin-2 receptor α (IL-2R α) on T cells during activation. Expression of transferrin receptors and the CD3 molecules is not down-regulated by this factor. The AS-9 SF consequently blocks proliferation of T cells when they are stimulated by lectin or activated through the T cell receptors. AS-9 SF suppresses the IL-2R α induction and the T cell proliferation at the induction phase only because it has no suppressive effect on preactivated T cells. Interleukin-2, IL-2R α, and β messages are not down-regulated by the AS-9 SF and the suppressive effect of the AS-9 SF on IL-2R α expression and on T cell proliferation is not neutralized by the addition of exogenous recombinant IL-2. The factor does not appear to be IL-4, IL-10, or TGF-β, three known cytokines possessing regulatory properties on T cell activation. © 1993 by Academic Press, Inc.
引用
收藏
页码:256 / 262
页数:7
相关论文
共 31 条
[1]   CLONAL ANALYSIS OF CYTO-TOXIC LYMPHOCYTE-T RESPONSE TO AUTOLOGOUS HUMAN METASTATIC MELANOMA [J].
ANICHINI, A ;
FOSSATI, G ;
PARMIANI, G .
INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (05) :683-689
[2]   THE ROLE OF THE T-CELL RECEPTOR IN POSITIVE AND NEGATIVE SELECTION OF DEVELOPING T-CELLS [J].
BLACKMAN, M ;
KAPPLER, J ;
MARRACK, P .
SCIENCE, 1990, 248 (4961) :1335-1341
[3]  
CHAKRABORTY N G, 1991, In Vivo (Attiki), V5, P609
[4]  
CHAKRABORTY NG, 1990, J IMMUNOL, V145, P2359
[5]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]  
DEVRIES JE, 1984, J IMMUNOL, V132, P510
[7]  
DUMONT FJ, 1990, J IMMUNOL, V144, P251
[8]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[9]   2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES [J].
FIORENTINO, DF ;
BOND, MW ;
MOSMANN, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :2081-2095
[10]  
GERSHON RK, 1975, TRANSPLANT REV-DENMA, V26, P170